NCT02342925View on ClinicalTrials.gov

A Study of the Effect of RG1662 on Metformin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy Volunteer
Interventions
OTHER

Omnipaque 300

647 mg/mL of iohexol, equivalent to 300 mg/mL of iodine, used for assessment of glomerular function and other measure of renal function

DRUG

RG1662

Oral administration twice daily

DRUG

metformin

Single 850 mg dose of metformin

Trial Locations (1)

LS2 9LH

Leeds

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02342925 - A Study of the Effect of RG1662 on Metformin in Healthy Volunteers | Biotech Hunter | Biotech Hunter